Supplement for "Delgocitinib ointment in pediatric patients with atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study"

Published: 10 June 2021| Version 1 | DOI: 10.17632/6yrdmwydzj.1
Contributor:
Manabu Oda

Description

Supplementary Information and Results - Nakagawa H, et al. Delgocitinib ointment in pediatric patients with atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study.

Files